Drug Profile
LBVE 014
Alternative Names: LBVE014Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for phase-I development in Pneumococcal-infections(Prevention, In volunteers) in South Korea
- 08 Sep 2016 Phase-I clinical trials in Pneumococcal infections (Prevention, In volunteers) in South Korea (unspecified route) (NCT02892812)